Cantabio Pharmaceuticals

Cantabio Pharmaceuticals

Cantabio Pharmaceuticals is focused on bringing novel, first-in-class drug candidates and diagnostics into clinical trials and beyond for Parkinson’s, Alzheimer and Diabetic Kidney diseases through the discovery and development of innovative pharmacological chaperone and protein delivery-based therapeutics aimed at addressing the reduction of biochemical stress such as protein aggregation, oxidative and glyoxal stress, the root causes of various diseases.

VISIT WEBSITE

Subscribe To Our Newsletter

Join our mailing list to get updated with our latest news and events!

Contact Information
  • Lee Kong Chian School of
    Medicine,
    Clinical Sciences Building
    11 Mandalay Road #16-01
    Singapore 308232

  • +65 6904 1401
Members Login

co11ab Novena (co11ab) is a Bio MedTech incubator – forged through a tripartite alliance between Nanyang Technological University, Singapore (NTU Singapore), Agency for Science, Technology, and Research (A*STAR), and National Healthcare Group (NHG) – which aims to nurture and support the translational development of biomedical technologies. Our key focus areas are biotech, medtech and digital health.